DM0000: The mark consists of the stylized wording "FUJIREBIO NEURO CENTER OF EXCELLENCE" in black to the right of a black vertical line; a design of two hands outlined in blue sit below an incomplete circle design consisting of two halves; one side being a half of a brain outlined in green, and the other side being half of a globe outlined in blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.
CC0000: The color(s) blue, green and black is/are claimed as a feature of the mark.
D10000: "NEURO CENTER OF EXCELLENCE"
GS0421: Research services for reagents for medical use in the field of neurology; research services for reagents for medical use; medical research and medical analysis for medical research in the field of neurology, and consulting relating thereto; analysis for medical research and medical research services and consulting about the aforesaid; scientific testing, analysis and research for medical purposes in the field of neurology; scientific testing, analysing and research for medical purposes in the field of neurology; scientific and medical research and development in the field of neurology; scientific and medical research and development in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals in the field of neurology; testing, inspection and research of chemicals and pharmaceuticals; testing, inspection and research of cosmetics and foodstuffs; research and development in the field of diagnostic preparations relating to neurology; research and development in the field of diagnostic preparations; providing information relating to medical research in the field of medicine, chemistry and diagnostics relating to neurology; providing information relating to medical research in the field of medicine, chemistry and diagnostics; working on and evaluation of chemical analyses in the field of neurology; working on and evaluation of chemical analyses; consultancy in the field of chemistry relating to neurology; consultancy in the field of chemistry; testing, inspection and research of chemicals and pharmaceuticals relating to chemistry in the field of neurology; testing, inspection and research of diagnostic agents relating to chemistry; testing, inspection, research, evaluation and analysis of chemical ingredients in the field of neurology; testing, inspection, research, evaluation and analysis of chemical ingredients; product research and development services; product development consultancy; providing quality assurance services in the field of neurology; quality assurance consultancy services in the field of neurology; product quality testing; material testing and analysis for product quality; testing the functionality of, and research on, machines, apparatus and instruments; testing the functionality of, and research relating to, medical apparatus and instruments in the field of neurology, and their parts; testing the functionality of, and research relating to, medical apparatus and instruments and their parts; design of medical apparatus and instruments in the field of neurology; design of medical apparatus and instruments; design and development of diagnostic apparatus; design and development of medical diagnostic apparatus in the field of neurology; design and development of medical diagnostic apparatus; rental of laboratory apparatus for chemical substances in the field of neurology; rental of laboratory apparatus for chemical substances; rental of measuring apparatus; rental of measuring and laboratory machines and instruments; rental of laboratory apparatus and instruments; rental of computers; providing computer programs on data networks, namely, providing temporary use of online non-downloadable software for database management in the field of neurology; computer software design, computer programming, and maintenance of computer software; scientific and medical research and development in the field of neurology by collaborating with third parties; scientific and medical research and development by collaborating with third parties; scientific research, testing and analysis services by engineers and scientists, and their technological consultancy services in the field of neurology; pharmaceutical product evaluation by engineers and scientists, and its technological consultancy services; evaluation of chemical analyses by engineers and scientists, and its technological consultancy services
Case File Event Statements
3/4/2024 - 10 months ago
30 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
2/9/2024 - 11 months ago
29 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
2/9/2024 - 11 months ago
28 - FINAL DISPOSITION PROCESSEDType:FIMP
2/7/2024 - 11 months ago
27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
2/2/2024 - 11 months ago
26 - CHANGE OF NAME/ADDRESS REC'D FROM IBType:ADCH
11/7/2023 - a year ago
25 - NOTICE OF REGISTRATION CONFIRMATION EMAILEDType:NRCC
11/7/2023 - a year ago
24 - REGISTERED-PRINCIPAL REGISTERType:R.PR
8/22/2023 - a year ago
23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
8/22/2023 - a year ago
22 - PUBLISHED FOR OPPOSITIONType:PUBO
8/21/2023 - a year ago
21 - NOTIFICATION PROCESSED BY IBType:GPNX
8/2/2023 - a year ago
20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
8/2/2023 - a year ago
19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
8/2/2023 - a year ago
18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
7/18/2023 - a year ago
17 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
7/18/2023 - a year ago
16 - EXAMINER'S AMENDMENT ENTEREDType:XAEC
7/18/2023 - a year ago
15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDType:GNEN
7/18/2023 - a year ago
14 - EXAMINERS AMENDMENT E-MAILEDType:GNEA
7/18/2023 - a year ago
13 - EXAMINERS AMENDMENT -WRITTENType:CNEA
7/7/2023 - a year ago
12 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
7/6/2023 - a year ago
11 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
7/6/2023 - a year ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
6/26/2023 - a year ago
9 - REFUSAL PROCESSED BY IBType:RFNT
6/6/2023 - a year ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
6/6/2023 - a year ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
4/8/2023 - a year ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
4/7/2023 - a year ago
5 - NON-FINAL ACTION WRITTENType:CNRT
3/21/2023 - a year ago
4 - ASSIGNED TO EXAMINERType:DOCK
10/11/2022 - 2 years ago
3 - APPLICATION FILING RECEIPT MAILEDType:MAFR
10/7/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
10/6/2022 - 2 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
Trademark
79351939
